SCHEMBL23438796

SCHEMBL23438796

c1ccc(-c2ccc(N(c3ccc(-c4ccccc4)c(-c4ccccc4)c3)c3ccc(-c4ccccc4)c(-c4cccc5c4oc4ccccc45)c3)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 3/20 0.48
▸ GGPS1 O95749 1/20 0.38
▸ PRKDC P78527 7/20 0.37
▸ PTGES2 Q9H7Z7 1/20 0.36
▸ CDC14B O60729 2/20 0.34
▸ CDC14A Q9UNH5 2/20 0.34
▸ PIK3CD O00329 1/20 0.34
▸ PIK3CB P42338 1/20 0.34
▸ PLA2G2A P14555 3/20 0.34
▸ PLA2G4A P47712 3/20 0.34
▸ ATM Q13315 1/20 0.34
▸ HDAC8 Q9BY41 1/20 0.33
▸ TNKS O95271 1/20 0.33
▸ PLA2G10 O15496 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ CSF1R P07333 1/20 0.32
▸ PDGFRB P09619 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ KIT P10721 1/20 0.32
▸ FLT3 P36888 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23438818 0.99 ALOX5 (0.49) ALOX5GGPS1PRKDCPTGES2CDC14B
SCHEMBL25628869 0.98 ALOX5 (0.46) ALOX5GGPS1PRKDCPTGES2CDC14B
SCHEMBL23438843 0.97 ALOX5 (0.48) ALOX5GGPS1PRKDCPTGES2CDC14B
SCHEMBL22159503 0.97 ALOX5 (0.48) ALOX5GGPS1PRKDCPTGES2CDC14B
SCHEMBL21588549 0.97 ALOX5 (0.50) ALOX5GGPS1PRKDCPTGES2CDC14B
SCHEMBL23438458 0.96 ALOX5 (0.51) ALOX5GGPS1PRKDCPTGES2CDC14B
SCHEMBL17917849 0.96 ALOX5 (0.49) ALOX5GGPS1PRKDCPTGES2CDC14B
SCHEMBL17918109 0.96 ALOX5 (0.49) ALOX5GGPS1PRKDCPTGES2CDC14B
SCHEMBL17917828 0.96 ALOX5 (0.49) ALOX5GGPS1PRKDCPTGES2CDC14B
SCHEMBL17917957 0.96 ALOX5 (0.49) ALOX5GGPS1PRKDCPTGES2CDC14B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210163411-A1 COMPOUND HAVING TRIARYLAMINE STRUCTURE AS CORE, AND PREPARATION METHOD THEREFOR JIANGSU SUNERA TECHNOLOGY CO., LTD. (CN) 2021-06-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210163411-A1 COMPOUND HAVING TRIARYLAMINE STRUCTURE AS CORE, AND PREPARATION METHOD THEREFOR WEE1, WEE2, ALOX12 ALOX5 41/4885GGPS1 72/4885PRKDC 4163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback